Management of pancreatic pseudocysts

Pancreatic pseudocysts remain a clinical challenge due to their variable presentation and diagnostic accuracy. Prior research has shown that imaging techniques such as ultrasound, CT scans, and ERCP are commonly used for detection. However, the reliability of these methods in identifying pseudocysts has not been fully resolved. No prior work had resolved the comparative effectiveness of these modalities in a large cohort. That uncertainty drove the need for a systematic evaluation of diagnostic accuracy across modalities. The gap in understanding how pseudocyst size correlates with clinical outcomes remains significant. Researchers have not yet determined the optimal management strategy for pseudocysts under 4 cm. This study aimed to clarify the role of imaging in pseudocyst diagnosis and the implications of pseudocyst size on treatment decisions. The findings could inform guidelines for non-operative management in selected cases.

This study aimed to evaluate the accuracy of diagnostic imaging in identifying pancreatic pseudocysts and to assess the clinical outcomes of patients based on pseudocyst size. Researchers focused on the performance of ultrasound, CT scans, and ERCP in a cohort of 55 patients. The motivation stemmed from the lack of consensus on the best imaging modality for pseudocyst detection. The study also sought to determine whether pseudocysts under 4 cm could be safely observed without surgery. Prior studies had not addressed the relationship between pseudocyst size and clinical regression. The researchers aimed to clarify the role of serial imaging in monitoring smaller pseudocysts. They also wanted to compare the outcomes of surgical and non-surgical management. The ultimate goal was to provide evidence for a size-based management strategy.

The study reviewed medical records of 55 patients with pancreatic pseudocysts over a ten-year period. Imaging data from CT scans, ultrasound, and ERCP were analyzed for diagnostic accuracy. Researchers categorized patients based on pseudocyst size and treatment approach. Surgical outcomes were compared with non-surgical outcomes in a subgroup of 15 patients. The study used a retrospective design to assess diagnostic performance and clinical outcomes. Researchers calculated sensitivity and false-positive rates for each imaging modality. They also tracked mortality and complications in the surgical group. The non-surgical group was monitored for pseudocyst regression using serial imaging.

CT scans demonstrated the highest diagnostic accuracy with 92% sensitivity and 8% false-positive rate. Ultrasound had 10% sensitivity and 5% false-positive rate in the surgical group. ERCP showed 83% sensitivity with one false-negative and one indeterminate result. Mortality among 39 surgical patients was 21%, primarily due to sepsis. In the non-surgical group, 15 patients were followed based on pseudocyst size. Five had pseudocysts larger than 4 cm, with only one showing regression. Ten had pseudocysts under 4 cm, and nine showed clinical regression. The data suggest that smaller pseudocysts may be safely observed with serial imaging. No significant complications were reported in the non-surgical group.

The study suggests that pseudocysts 4 cm or smaller may be safely observed using serial CT or ultrasound. Larger pseudocysts appear to require surgical intervention based on the low regression rate. The findings support a size-based approach to management rather than routine surgery. CT scans outperformed ultrasound and ERCP in diagnostic accuracy. The high mortality in the surgical group highlights the risks of invasive treatment. Researchers propose that non-operative management is viable for selected patients. Serial imaging can monitor pseudocyst changes over time. The authors emphasize the need for individualized treatment plans based on pseudocyst size.